A paediatric investigation plan (PIP) is a development plan intended to support the authorisation of a medicine for children by ensuring data are obtained through studies in the paediatric population.
Our consultants can advise as to whether a deferral or waiver may be appropriate and can provide a complete PIP writing service as well as any PIP modifications through the lifecycle of the product within the EU or US.
